SIGA
Siga Technologies Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Siga Technologies Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
No other changes.
No other changes.
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Mar 10 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 10 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of Siga Technologies Inc's 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of Siga Technologies Inc's 6 closest co-movers, none share that code.
−2.24%
vs ±27.9% implied · ×0.08
shaded = implied · ▲▼ = realized
Siga Technologies Inc
3.13
−0.02 · −0.77%
Tall tick = annual report · Source: EDGAR
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $15.2M | 11.99% | +19.81% |
| Dimensional | $9.9M | 7.79% | +0.62% |
| AltraVue Capital | $8.5M | 6.67% | −4.31% |
| Vanguardindex-like | $6.2M | 4.91% | −0.10% |
| American Century Companies | $5.5M | 4.31% | +14.29% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $15.2M | 11.99% | +19.81% |
| Dimensional | $9.9M | 7.79% | +0.62% |
| AltraVue Capital | $8.5M | 6.67% | −4.31% |
| Vanguardindex-like | $6.2M | 4.91% | −0.10% |
| American Century Companies | $5.5M | 4.31% | +14.29% |
Expected move
Inputsspot 3.11exp Nov 20ATM strike 3ATM straddle 1.85IV 372%
Bull2
Bear2